<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene wt1 (<z:hpo ids='HP_0002667'>Wilms tumor</z:hpo> 1) encodes a zinc finger transcription factor reported to be expressed in many <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, including <z:mpath ids='MPATH_365'>mesotheliomas</z:mpath>, <z:mp ids='MP_0002038'>carcinomas</z:mp>, and <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, WT1 expression in non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHLs) has not been studied </plain></SENT>
<SENT sid="2" pm="."><plain>The authors assessed for WT1 expression in six <z:hpo ids='HP_0002665'>lymphoma</z:hpo>/<z:hpo ids='HP_0001909'>leukemia</z:hpo> cell lines using Western blot methods after subcellular fractionation </plain></SENT>
<SENT sid="3" pm="."><plain>We also assessed for WT1 expression in 167 NHLs using immunohistochemical methods </plain></SENT>
<SENT sid="4" pm="."><plain>The B-cell NHLs analyzed were 18 diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 13 marginal zone B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 9 small lymphocytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCLs</z:e>), 8 follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 6 mantle cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 5 Burkitt <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 3 lymphoplasmacytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, and 2 B-cell lymphoblastic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The T-cell NHLs analyzed were 43 anaplastic large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCLs</z:e>), 26 peripheral T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> unspecified, 13 angioimmunoblastic T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 6 cutaneous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCLs</z:e>, 6 cases of <z:e sem="disease" ids="C0026948" disease_type="Neoplastic Process" abbrv="">mycosis fungoides</z:e>, 5 extranodal NK/T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of nasal type, and 4 T-cell lymphoblastic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>WT1 levels were higher in cytoplasmic extracts than in nuclear extracts of the Karpas 299 and SU-DHL-1 <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines but were higher in nuclear extracts than in the cytoplasmic extracts of the Jurkat, HH, U-937, and K562 <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell lines </plain></SENT>
<SENT sid="7" pm="."><plain>In NHLs, WT1 was positive in 4 of 5 (80%) Burkitt <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 9 of 12 (75%) ALK-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCLs</z:e>, 3 of 6 (50%) lymphoblastic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (2 of 4 T-cell, 1 of 2 B-cell), 14 of 31 (45%) ALK-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCLs</z:e>, 6 of 18 (33%) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCLs</z:e>, and 1 of 6 (17%) cutaneous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCLs</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>WT1 was negative in <z:hpo ids='HP_0000001'>all</z:hpo> other NHLs tested </plain></SENT>
<SENT sid="9" pm="."><plain>WT1 immunoreactivity was primarily cytoplasmic in <z:hpo ids='HP_0000001'>all</z:hpo> positive NHLs except T-cell lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, WT1 protein is frequently detected in the cytoplasm of a subset of high-grade NHLs </plain></SENT>
</text></document>